Investigational Site Number :2500003
Nantes 44093
0 studies enrolling now · 3 studies all time
What they study most
Atopic Dermatitis, Malignant Solid Tumor, Plasma Cell Myeloma
Studies at this site
- A Study to Investigate the Clinical Benefit of Isatuximab in Combination With Bortezomib, Lenalidomide and Dexamethasone in Adults With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant — Running, not enrolling
- SAR231893-LPS15497- "Dupilumab Effect on Sleep in AD Patients" — Completed
- A First-in-human Study of the Safety, Pharmacokinetics, Pharmacodynamics and Anti-tumor Activity of SAR439459 Monotherapy and Combination of SAR439459 and Cemiplimab in Patients With Advanced Solid Tumors — Completed